{"id":55595,"date":"2025-12-01T15:40:07","date_gmt":"2025-12-01T10:10:07","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=55595"},"modified":"2025-12-01T15:40:32","modified_gmt":"2025-12-01T10:10:32","slug":"ravelcare-ipo-gmp-day-1","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/ravelcare-ipo-gmp-day-1\/","title":{"rendered":"Ravelcare\u00a0 IPO GMP: Day 1 IPO Live Updates"},"content":{"rendered":"<p>The <strong>Ravelcare&nbsp; IPO GMP <\/strong>is \u20b916 as of 1st December 2025. It is a bookbuilding IPO of \u20b924.10 crores. This is an entirely fresh issue of 19,00,000 shares. The issue will be listed on BSE and SME on its tentative listing date, 8th December 2025. The face value of Ravelcare&nbsp; IPO shares is \u20b910 per share, and the IPO price band is \u20b9123 to \u20b9130 per share. Retail investors can bid for a minimum of 2 lots of 2,000 shares worth \u20b92,52,000.<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/ravelcare-ipo-gmp-day-1\/#Ravelcare_IPO_GMP_Grey_Market_Premium\" title=\"Ravelcare&nbsp; IPO GMP Grey Market Premium\">Ravelcare&nbsp; IPO GMP Grey Market Premium<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/ravelcare-ipo-gmp-day-1\/#Ravelcare_IPO_Details\" title=\"Ravelcare&nbsp; IPO Details\">Ravelcare&nbsp; IPO Details<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/ravelcare-ipo-gmp-day-1\/#Explanation\" title=\"Explanation\">Explanation<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/ravelcare-ipo-gmp-day-1\/#Ravelcare_IPO_Objectives\" title=\"Ravelcare&nbsp; IPO Objectives\">Ravelcare&nbsp; IPO Objectives<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/ravelcare-ipo-gmp-day-1\/#Ravelcare_IPO_Registrar\" title=\"Ravelcare&nbsp; IPO Registrar\">Ravelcare&nbsp; IPO Registrar<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/ravelcare-ipo-gmp-day-1\/#Ravelcare_IPO_Review\" title=\"Ravelcare&nbsp; IPO Review\">Ravelcare&nbsp; IPO Review<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/ravelcare-ipo-gmp-day-1\/#Ravelcare_IPO_Limited_Technicals\" title=\"Ravelcare&nbsp; IPO Limited Technicals\">Ravelcare&nbsp; IPO Limited Technicals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/ravelcare-ipo-gmp-day-1\/#FAQs_on_Ravelcare_IPO\" title=\"FAQs on Ravelcare&nbsp; IPO\">FAQs on Ravelcare&nbsp; IPO<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/ravelcare-ipo-gmp-day-1\/#What_is_the_Ravelcare_IPO_GMP\" title=\"What is the Ravelcare&nbsp; IPO GMP?\">What is the Ravelcare&nbsp; IPO GMP?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/ravelcare-ipo-gmp-day-1\/#What_is_the_issue_price_of_Ravelcare_IPO\" title=\"What is the issue price of Ravelcare&nbsp; IPO?\">What is the issue price of Ravelcare&nbsp; IPO?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/ravelcare-ipo-gmp-day-1\/#Who_is_the_registrar_of_Ravelcare_IPO\" title=\"Who is the registrar of Ravelcare&nbsp; IPO?\">Who is the registrar of Ravelcare&nbsp; IPO?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/ravelcare-ipo-gmp-day-1\/#Recent_Articles\" title=\"Recent Articles\">Recent Articles<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ravelcare_IPO_GMP_Grey_Market_Premium\"><\/span><strong>Ravelcare&nbsp; IPO GMP Grey Market Premium<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>As of 1st December 2025, the <strong>Ravelcare&nbsp; IPO GMP <\/strong>stands at \u20b916 per share. Thus, the estimated listing price would be \u20b9146. This indicates that the estimated listing gain in this IPO could be 12.31%. However, GMP details are subject to change based on market conditions and fluctuations. Explore the table for the <strong>Ravelcare&nbsp; IPO GMP<\/strong> updates.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>GMP Date<\/strong><\/td><td><strong>IPO Price<\/strong><\/td><td><strong>GMP<\/strong><\/td><td><strong>Estimated Listing Price&nbsp;<\/strong><\/td><td><strong>Estimated Listing Gains<\/strong><\/td><\/tr><tr><td><strong>1-12-2025<\/strong><\/td><td>\u20b9130.00<\/td><td>\u20b952.00<\/td><td>\u20b9182.00<\/td><td>40.00%<\/td><\/tr><tr><td><strong>30-11-2025<\/strong><\/td><td>\u20b9130.00<\/td><td>\u20b916.00<\/td><td>\u20b9146.00<\/td><td>12.31%<\/td><\/tr><tr><td><strong>29-11-2025<\/strong><\/td><td>\u20b9130.00<\/td><td>\u20b916.00<\/td><td>\u20b9146.00<\/td><td>12.31%<\/td><\/tr><tr><td><strong>28-11-2025<\/strong><\/td><td>\u20b9130.00<\/td><td>\u20b916.00<\/td><td>\u20b9146.00<\/td><td>12.31%<\/td><\/tr><tr><td><strong>27-11-2025<\/strong><\/td><td>\u20b9130.00<\/td><td>\u20b916.00<\/td><td>\u20b9146.00<\/td><td>12.31%<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ravelcare_IPO_Details\"><\/span><strong>Ravelcare&nbsp; IPO Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>IPO Open Date<\/strong><\/td><td>1st December 2025<\/td><\/tr><tr><td><strong>IPO Close Date<\/strong><\/td><td>3rd December 2025<\/td><\/tr><tr><td><strong>IPO Allotment Date<\/strong><\/td><td>4th December 2025<\/td><\/tr><tr><td><strong>Refund Initiation&nbsp;<\/strong><\/td><td>5th December 2025<\/td><\/tr><tr><td><strong>Face Value<\/strong><\/td><td>\u20b910 per share<\/td><\/tr><tr><td><strong>Price Band<\/strong><\/td><td>\u20b9123 to \u20b9130 per share<\/td><\/tr><tr><td><strong>Lot Size<\/strong><\/td><td>1,000 Shares<\/td><\/tr><tr><td><strong>Issue Size<\/strong><\/td><td>18,54,000 shares(aggregating up to \u20b924.10 Cr)<\/td><\/tr><tr><td><strong>Issue Type&nbsp;<\/strong><\/td><td>Bookbuilding IPO<\/td><\/tr><tr><td><strong>Listing At<\/strong><\/td><td>BSE and SME<\/td><\/tr><tr><td><strong>Listing Date<\/strong><\/td><td>8th December 2025<\/td><\/tr><\/tbody><\/table><\/figure><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Explanation\"><\/span><strong>Explanation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p><strong>Ravelcare&nbsp; IPO<\/strong>: Ravelcare&nbsp; IPO Limited has declared an issue price band of \u20b9123.00 to \u20b9130.00 per share. With this IPO, the company allows retail investors to bid for at least two lots of 2,000 shares, each worth \u20b92,60,000. The face value of Ravelcare&nbsp; IPO Limited shares is \u20b910 per share. The shares of Ravelcare&nbsp; IPO Limited will be listed on BSE and SME on its tentative listing day, 8th December 2025. Scroll down to check GMP updates and <strong>Ravelcare&nbsp; IPO <\/strong>reviews.&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ravelcare_IPO_Objectives\"><\/span><strong>Ravelcare&nbsp; IPO Objectives<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>The primary aim of the <strong>Ravelcare IPO<\/strong> is to raise \u20b924.10 crores. On the other hand, Ravelcare has decided to utilise these funds in different ways. Explore some of the secondary objectives for the <strong>Ravelcare IPO<\/strong>.<\/p><ul class=\"wp-block-list\"><li>Marketing and advertising expenses toward enhancing the awareness and visibility of the brand<\/li>\n\n<li>Setting up a new manufacturing facility located at Mauje-Peth in Amravati (\u201cProposed facility\u201d)<\/li>\n\n<li>To meet general corporate purposes<\/li><\/ul><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ravelcare_IPO_Registrar\"><\/span><strong>Ravelcare&nbsp; IPO Registrar<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>According to recent updates, Kfin Technologies Private Limited will be the registrar responsible for managing allotment and refund procedures. For any queries regarding the Ravelcare&nbsp; IPO GMP, allotment, or refund, please contact the investor relations team at Kfin Technologies Private Limited&nbsp; <a href=\"mailto:reachus@kfintech.com\">reachus@kfintech.com<\/a> or 04067162222, 04079611000.&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ravelcare_IPO_Review\"><\/span><strong>Ravelcare&nbsp; IPO Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"536\" src=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/01153708\/Ravelcare-IPO-Apply-or-Avoid-1024x536.jpg\" alt=\"Ravelcare  IPO GMP Review\n\" class=\"wp-image-55597\" srcset=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/01153708\/Ravelcare-IPO-Apply-or-Avoid-1024x536.jpg 1024w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/01153708\/Ravelcare-IPO-Apply-or-Avoid-300x157.jpg 300w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/01153708\/Ravelcare-IPO-Apply-or-Avoid-768x402.jpg 768w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/01153708\/Ravelcare-IPO-Apply-or-Avoid-900x471.jpg 900w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/01153708\/Ravelcare-IPO-Apply-or-Avoid-600x314.jpg 600w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/01153708\/Ravelcare-IPO-Apply-or-Avoid-150x79.jpg 150w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/01153708\/Ravelcare-IPO-Apply-or-Avoid.jpg 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><p>The <strong>Ravelcare&nbsp; IPO <\/strong>has gained neutral ratings from industry experts, brokers, and institutional investors. Ravelcare&nbsp; Limited&#8217;s revenue increased by 14% from \u20b922.28 crore in March 2024 to \u20b925.30 crore in March 2025. Moreover, the company\u2019s PAT increased by 5% from \u20b95.02 crores to \u20b95.26 crores. Investors can analyse other relevant factors and make a decision accordingly.<\/p><p>Investors can analyse other relevant factors and make a decision accordingly.<\/p><p>Most analysts recommend applying for this IPO to diversify your investment portfolio. However, we\u2019re waiting for additional ratings to get a clearer picture and will keep posting them to deliver real-time insights. Until then, you can explore the company&#8217;s technical analysis to know whether you should apply for <strong>Ravelcare&nbsp; IPO <\/strong>or not.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ravelcare_IPO_Limited_Technicals\"><\/span><strong>Ravelcare&nbsp; IPO Limited Technicals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Key Indicators<\/strong><\/td><td><strong>Value<\/strong><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/price-to-earnings-ratio-p-e-ratio\"><strong>PE Ratio (Price-to-Earnings)&nbsp;<\/strong><\/a><\/td><td>12.38<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/earnings-per-share-eps-formula\"><strong>EPS (Earnings Per Share)<\/strong><\/a><\/td><td>10.50<\/td><\/tr><tr><td><strong>RoNW<\/strong><\/td><td>50.77%<\/td><\/tr><tr><td><strong>ROCE<\/strong><\/td><td>68.32%<\/td><\/tr><tr><td><strong>ROE<\/strong><\/td><td>68.04%<\/td><\/tr><tr><td><strong>EBITDA Margin<\/strong><\/td><td>27.30%<\/td><\/tr><tr><td><strong>Price to Book Value<\/strong><\/td><td>6.29<\/td><\/tr><tr><td><strong>Market Capitalisation<\/strong><\/td><td>\u20b989.17 Cr.<\/td><\/tr><\/tbody><\/table><\/figure><p>The P\/E ratio of Ravelcare&nbsp; Limited&#8217;s shares is 12.38, and its Earnings Per Share (EPS) is 10.50. Thus, the <strong>Ravelcare&nbsp; Limited IPO<\/strong> can deliver gains on its tentative listing day, 3rd December 2025<\/p><p><strong><em>Note<\/em><\/strong><em>: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Ravelcare&nbsp; IPO Limited are subject to change after the IPO. Refer to the table below for post-issue updates on these two metrics.&nbsp;<\/em><\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Indicators<\/strong><\/td><td><strong>Pre-IPO<\/strong><\/td><td><strong>Post-IPO<\/strong><\/td><\/tr><tr><td><strong>PE Ratio<\/strong><\/td><td>12.38<\/td><td>13.95<\/td><\/tr><tr><td><strong>EPS&nbsp;<\/strong><\/td><td>10.50<\/td><td>9.32<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"FAQs_on_Ravelcare_IPO\"><\/span><strong>FAQs on Ravelcare&nbsp; IPO<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_is_the_Ravelcare_IPO_GMP\"><\/span><strong>What is the Ravelcare&nbsp; IPO GMP?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Currently, on 1st December 2025, the <strong>Ravelcare&nbsp; IPO GMP<\/strong> (Grey Market Premium) stands at \u20b952. This indicates that the estimated listing price could be \u20b9182 per share.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_is_the_issue_price_of_Ravelcare_IPO\"><\/span><strong>What is the issue price of Ravelcare&nbsp; IPO?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>The <strong>Ravelcare IPO<\/strong> issue price band is set at \u20b9123 to \u20b9130 per share. Retail investors can apply for a minimum of 2 lots consisting of 2,000 shares worth \u20b92,60,000. Moreover, HNIs are required to bid for a minimum of 3 lots (3,000 shares) worth \u20b93,90,000.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Who_is_the_registrar_of_Ravelcare_IPO\"><\/span><strong>Who is the registrar of Ravelcare&nbsp; IPO?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Kfin Technologies Limited is the registrar for the Ravelcare IPO, awaiting to manage the allotment process and initiate refunds. For any queries regarding the Ravelcare allotment and refund, you can contact Kfin Technologies Limited at <a href=\"mailto:reachus@kfintech.com\">reachus@kfintech.com<\/a> or 04067162222, 04079611000.&nbsp;<\/p><p><strong><em>Disclaimer<\/em><\/strong><em>: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Ravelcare&nbsp; IPO, download the Ravelcare&nbsp; IPO RHP and Ravelcare&nbsp; IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.<\/em><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Articles\"><\/span><strong>Recent Articles<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/max-healthcare-q1-results-fy26\">Max Healthcare Q1 Results FY26: Q1 PAT Rises 30.35% to \u20b9307.97 Crore; Revenue Up 31.41% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/minda-corporation-q1-results-fy26\">Minda Corporation Q1 Results FY26: Q1 PAT Rises 1.73% to \u20b965.31 Crore; Revenue Up 16.23% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/bharat-dynamics-q1-results-fy26\">Bharat Dynamics Q1 Results FY26: Q1 PAT Rises 154.30% to \u20b918.35 Crore; Revenue Up 29.69% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/elitecon-international-q1-results-fy26\">Elitecon International Q1 Results FY26: Q1 PAT Rises 349.99% to \u20b920.41 Crore; Revenue Up 301.98% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/elgi-equipments-q1-results-fy26\">Elgi Equipments Q1 Results FY26: Q1 PAT Rises 17.58% to \u20b985.60 Crore; Revenue Up 8.19% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/aavas-financier-q1-results-fy26\">Aavas Financier Q1 Results FY26: Q1 PAT Rises 10.41% to \u20b9139.23 Crore; Revenue Up 15.70% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/regaal-resources-ipo-gmp-2\">Ravelcare&nbsp; IPO GMP: Day 2 IPO Live Updates<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>The Ravelcare&nbsp; IPO GMP is \u20b916 as of 1st December 2025. It is a bookbuilding IPO of \u20b924.10 crores. This is an entirely fresh issue of 19,00,000 shares. The issue will be listed on BSE and SME on its tentative listing date, 8th December 2025. The face value of Ravelcare&nbsp; IPO shares is \u20b910 per<\/p>\n","protected":false},"author":23,"featured_media":55596,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1281],"tags":[3530],"class_list":["post-55595","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo","tag-ravelcare-ipo-gmp"],"metadata":{"_edit_lock":["1764583832:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"amazonS3_cache":["a:4:{s:80:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2025\/12\/Ravelcare-IPO-Apply-or-Avoid.jpg\";a:2:{s:2:\"id\";i:55597;s:11:\"source_type\";s:13:\"media-library\";}s:89:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2025\/12\/Ravelcare-IPO-Apply-or-Avoid-1024x536.jpg\";a:2:{s:2:\"id\";i:55597;s:11:\"source_type\";s:13:\"media-library\";}s:112:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/01153708\/Ravelcare-IPO-Apply-or-Avoid.jpg\";a:2:{s:2:\"id\";i:55597;s:11:\"source_type\";s:13:\"media-library\";}s:121:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/01153708\/Ravelcare-IPO-Apply-or-Avoid-1024x536.jpg\";a:2:{s:2:\"id\";i:55597;s:11:\"source_type\";s:13:\"media-library\";}}"],"rank_math_primary_category":["1281"],"rank_math_seo_score":["75"],"rank_math_title":["Ravelcare IPO GMP Day 1 | Check IPO Details"],"rank_math_description":["Ravelcare IPO GMP status. Discover the IPO Price, Date, Subscription Status, Grey Market Premium (GMP), Allotment, Listing Date, and Review. Read more!\r\n"],"rank_math_focus_keyword":["Ravelcare IPO GMP"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["55596"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["4884"],"_wp_page_template":["default"],"rs_page_bg_color":[""],"rank_math_canonical_url":["https:\/\/univest.in\/blogs\/ravelcare-ipo-gmp-day-1"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/01153524\/Ravelcare-IPO-GMP-Day-1.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/55595","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=55595"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/55595\/revisions"}],"predecessor-version":[{"id":55598,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/55595\/revisions\/55598"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/55596"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=55595"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=55595"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=55595"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}